Peptable

Comparison

Melanotan I vs Tirzepatide

Function

While Melanotan I is approved in some regions for prevention of phototoxicity in erythropoietic protoporphyria and is studied as a skin-darkening, photoprotective peptide3444, Tirzepatide is approved for type 2 diabetes and obesity, producing larger HbA1c and body-weight reductions than semaglutide in head-to-head trials24.

Mechanism

While Melanotan I works as a linear 13-amino-acid analog of α-MSH (afamelanotide) that selectively activates MC1R on melanocytes, increasing eumelanin synthesis and providing photoprotection3444, Tirzepatide is a 39-amino-acid synthetic peptide primarily based on GIP sequence with C20 fatty diacid conjugation that acts as a dual agonist at GIP and GLP-1 receptors, enhancing glucose-dependent insulin secretion, suppressing glucagon, delaying gastric emptying, and reducing appetite24.

Receptor

Melanotan I

Melanocortin-1 receptor (MC1R) 344481

Tirzepatide

Glucose-dependent insulinotropic polypeptide receptor (GIPR) and GLP-1 receptor (GLP1R) 24

Organism or Origin

Melanotan I

Synthetic analog of human α-MSH derived from POMC34448190

Tirzepatide

Synthetic dual GIP/GLP-1 receptor agonist modeled on human incretin hormones2480

Gene

Melanotan I

POMC

Tirzepatide

Not assigned in the current dataset.

Summary

Both peptides fall into a similar broad context as Hormone peptides, although the details of how they are used and discussed still diverge. Their typical research and application settings separate fairly clearly: Melanotan I is more often discussed in the realm of Dermatology and aesthetics, whereas Tirzepatide is more often associated with the realm of Metabolic and endocrine and Cardiovascular health. Both appear to work through Receptor agonist, but the functional emphasis still separates, with Melanotan I leaning toward Melanogenesis modulation and Tirzepatide leaning toward Metabolic regulation and Lipolysis and fat loss. Both are synthetic in origin and their development context also differs, with Melanotan I approved for Research use only while Tirzepatide is approved. Melanotan I takes the form of a linear peptide, whereas Tirzepatide is closer to a peptide conjugate, while their sequence patterns also diverge, with Melanotan I showing protein-mimetic sequence features and Tirzepatide showing alpha-helical domain features.

Sources

34Melanotan I (Afamelanotide): Research Profile - PeptideJournal, https://www.peptidejournal.org/peptides/melanotan-i-research-profile
44Melanotan I: properties, applications and references, https://www.benchchem.com/zh/product/b1666627
81Proopiomelanocortin (POMC), the ACTH/melanocortin precursor, is ..., https://pmc.ncbi.nlm.nih.gov/articles/PMC2253185/
90alpha-Melanocyte stimulating hormone: production and degradation, https://pmc.ncbi.nlm.nih.gov/articles/PMC3936413/
24Tirzepatide - a dual GIP and GLP-1 (GLP1) receptor agonist, https://gpnotebook.com/pages/diabetes-and-endocrinology/tirzepatide-a-dual-gip-and-glp-1-glp1-receptor-agonist
80GLP-1 Localisation and Proglucagon Gene Expression in ..., https://pmc.ncbi.nlm.nih.gov/articles/PMC6200298/